Home Your basket
• Evaluation of quality of ...
   Price 10.50 €
• Adenocarcinoma of the eth...
   Price 8.50 €
• An original case of laryn...
   Price 8.50 €
• Mucus physiopathology, up...
   Price 12.50 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Fronto-ethmoidal mucocele...
   Price 8.50 €
• Interventional phoniatry...
   Price 14.00 €
• Actinomycosis of the midd...
   Price 5.50 €
• A clinico-radiological st...
   Price 10.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Aesthetic augmentation of...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Impaired laryngeal mobili...
   Price 10.50 €
• The pedicle superficial t...
   Price 10.50 €
• Bell's palsy: treatment b...
   Price 5.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Notes on voice and speech...
   Price 8.50 €
• Going from the tube feedi...
   Price 8.50 €
• The pedicled musculo-cuta...
   Price 8.50 €
• The «intra-cordal polyp»:...
   Price 5.50 €
• Analysis of the projectio...
   Price 8.50 €
• Audiological comparison b...
   Price 14.00 €
• Psychosocial quality of l...
   Price 10.50 €
• Non-functioning parathyro...
   Price 5.50 €
• Spontaneous cholesteatoma...
   Price 8.50 €
• Carcinogenesis of the eth...
   Price 10.50 €
• Vocal effectiveness in sp...
   Price 10.50 €
• Evolution of voice assess...
   Price 10.50 €
• Facial nerve outcome af...
   Price 12.50 €
• Interest of the chest CT ...
   Price 10.50 €
• Dehiscence of the superio...
   Price 10.50 €
• Revascularized free scapu...
   Price 10.50 €

Total Order 294.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

RHINOLOGY

Mucosal melanomas of the head and neck. Experience of the Salah Azaiz Institute (Tunis).


Authors : Z. Oueslati, S. Touati, S. Gritli, A. El-May, F. Benna, H. Boussen, A. El-Khedim, M. Ferjaoui, A. Ladgham (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:237-240.

Article published in french
Downloadable PDF document french



Summary : The mucosal melanoma of the head and neck is rare and of late diagnosis. This retrospective study concerns 17 cases brought together in 30 years. Sex-ratio was of 1,1, the average age of 58 years. Tumoral seats were the following ones : nasal cavity and paranasal sinus (n=10), nasopharyngeal cavity (n=2), gingival seat (n=2), palate (n=1), laryngeal seat (n=1), middle ear (n=1). Tumoral extension was classified an follows: stage I: 52,9%, stage II: 17,6%, stage III: 29,4%. Melanomas were achromic in 23,5% of cases. On the therapeutic plan, 47,1% of the patients were treated in a purpose palliative because of the importance of the tumoral extension. Seven patients (41,2%) were treated surgically ; three among them received an additional radiotherapy for an insufficient tumoral excision or adenopathy in break capsular. Two patients (11,8%) were treated by exclusive radiotherapy. The rates of survival were 17,6% in 2 years, and 5,9% in 5 years. The average duration of survival was of 18,1 months. The causes of failure were essentially local and metastatic.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE